"The impact of childhood cancers is profoundly devastating, both on the young patients and their families."
So says Bjarne Eggesbo, executive director and co-founder of the Bardo Foundation, a non-profit dedicated to advancing research and treatments for osteosarcoma, a rare bone cancer affecting children and young adults.
The foundation has announced a partnership with Iris.ai, a "pioneering provider of AI solutions for scientific text analysis and the European Innovation Council," which aims to use AI technology to "transform vast research into actionable knowledge" and "drive progress in oncology," per a press release.
Researchers at Oslo University Hospital will have access to Iris.ai's research tools, which the press release describes as " AI research tools designed to efficiently navigate and analyze vast volumes of academic literature and clinical data."
In osteosarcoma, "the primary challenge has been the disconnect between the volume of research available and the accessibility of new treatments available," Eggesbo says.
"By providing researchers with cutting-edge AI tools, we hope to bridge the gap between cutting-edge medical practice and clinical research, and ultimately help deliver relevant findings."
The project will initially focus on osteosarcoma, but the team hopes to scale it up to other rare cancers, per Gizmodo.
A customized collection of grant news from foundations and the federal government from around the Web.
Caroline Diehl is a serial social entrepreneur in the impact media space. She is Executive Chair and Founder of the UK’s only charitable and co-operatively owned national broadcast television channel Together TV, the leading broadcaster for social change runs a national TV channel in the UK and digital platform which helps people find inspiration to do good in their lives and communities.